When comparing semaglutide specifically against other diabetes and obesity drugs including Farxiga, metformin, and orlistat the reseachers again saw a higher rate of suicidal ideation reported for semaglutide, according to the study, published Tuesday in JAMA Network Open
Based on current trial populations and how the FDA has handled semaglutide and tirzepatide approvals, expected eligibility criteria are: BMI 30 , or BMI 27 with at least one weight-related condition (type 2 diabetes, hypertension, dyslipidemia, OSA) Adults 18 and older Not pregnant or breastfeeding No history of MTC or MEN 2 Retatrutide will almost certainly launch at a high price point estimates suggest $1,200$1,500 per month at list price
Improved Heart & Liver Health Excess weight can lead to high blood pressure, fatty liver disease, and cardiovascular issues
Will this trigger the next Olympic doping scandal
Have you ever wondered what might be lurking beneath the surface of your health